Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Renal Cell 14 Kidney Neoplasms 4 Uterine Cervical Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cystadenocarcinoma, Serous 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Renal Cell Carcinoma (RCC) 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Dexamethasone 116 daratumumab 70 Lenalidomide 66 Bortezomib 56 pomalidomide 46 carfilzomib 40 Cyclophosphamide 34 Specimen Handling 30 Calcium Dobesilate 30 Biopsy 27 Magnetic Resonance Spectroscopy 25 belantamab mafodotin 21 isatuximab 19 fludarabine 18 talquetamab 16 iberdomide 16 Melphalan 15 dexamethasone acetate 13 dexamethasone 21-phosphate 13 auricularum 13 fludarabine phosphate 11 selinexor 10 elotuzumab 10 tocilizumab 9 X-Rays 8 Nivolumab 8 Whole-Body Irradiation 7 Sirolimus 7 trametinib 6 Mycophenolic Acid 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Axitinib × 90 days × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡